Home / Health / Aloe Blacc Tackles Pancreatic Cancer After COVID
Aloe Blacc Tackles Pancreatic Cancer After COVID
15 Apr
Summary
- Singer Aloe Blacc aims to fund cancer research after his COVID experience.
- He is building a pancreatic cancer drug platform.
- Blacc is using a bootstrapping approach before seeking network investment.
Grammy-nominated artist Aloe Blacc has embarked on a new venture in biotech following his personal experience with COVID-19, even after vaccination and boosting. He discovered that direct financial contributions to research are complex due to regulatory hurdles and licensing issues.
Consequently, Blacc is now actively developing a cancer drug platform with a specific focus on pancreatic cancer, a disease with a very high mortality rate. He is employing a bootstrapping strategy for this initiative.
His plan is to present peer-reviewed research to his network before seeking substantial investment, highlighting a deliberate approach to building scientific validation first.
